In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity. — CFSMEATLAS
In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity.
Maes, Michael, Andrés-Rodríguez, Laura, Vojdani, Aristo et al. · CNS & neurological disorders drug targets · 2023 · DOI
Quick Summary
This study looked at people with schizophrenia who also experience fatigue and pain symptoms similar to ME/CFS and fibromyalgia. Researchers found that these symptoms may be caused by a breakdown in the intestinal barrier (the paracellular pathway), which allows harmful substances into the bloodstream and triggers immune system activation. This immune activation then produces neurotoxic byproducts that may cause the fatigue and pain symptoms.
Why It Matters
This study identifies potential shared mechanisms between ME/CFS-like symptoms and immune/intestinal barrier dysfunction, offering insights into pathways that may contribute to ME/CFS fatigue and pain. Understanding zonulin and paracellular barrier breakdown could inform future diagnostic and therapeutic approaches for ME/CFS patients. The work bridges psychiatric, immunological, and somatic symptom research, expanding understanding of how physical symptoms develop from immune activation.
Observed Findings
42.3% of fibromyalgia/chronic fatigue symptom variance was explained by paracellular/transcellular ratio, pro-inflammatory cytokines, IgM to zonulin, and IgA to tryptophan catabolites
Schizophrenia patients showed elevated zonulin levels and markers of paracellular tight-junction breakdown
Highly significant correlations existed between fibromyalgia-like symptoms and general cognitive decline, symptomatology, and quality of life
IgM responses to oxidative specific epitopes were inversely associated with fibromyalgia symptom severity
Inferred Conclusions
Paracellular pathway dysfunction and intestinal barrier breakdown (zonulin-mediated) drive physio-somatic symptoms in schizophrenia patients
Immune activation, tryptophan catabolite (TRYCAT) pathway induction, and resulting neurotoxicity constitute a key mechanism linking barrier dysfunction to fatigue and pain symptoms
Fibromyalgia-like symptoms represent part of a broader behavioral-cognitive-physical-psychosocial worsening phenotype in schizophrenia
Fatigue and pain symptoms in schizophrenia are organic, biologically-driven phenomena rather than purely psychiatric
Remaining Questions
Are the same paracellular pathway mechanisms present in primary ME/CFS patients without schizophrenia?
What This Study Does Not Prove
This study does not prove that paracellular pathway breakdown causes fatigue and pain symptoms—only that they are associated. The study was conducted in schizophrenia patients, so findings may not directly apply to primary ME/CFS; schizophrenia-related immune abnormalities may differ. Cross-sectional design cannot establish causality or temporal relationships between barrier dysfunction and symptom onset.